SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-016116
Filing Date
2022-04-27
Accepted
2022-04-27 09:09:17
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20003593x3_defa14a.htm DEFA14A 10034
2 ny20003593x3_nc1.jpg GRAPHIC 1604400
3 ny20003593x3_nc2.jpg GRAPHIC 904581
  Complete submission text file 0001140361-22-016116.txt   3321850
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34079 | Film No.: 22856636
SIC: 2834 Pharmaceutical Preparations